Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy.
about
Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials.Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer.Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method.Clinical significance of post-progression survival in lung cancerInfluence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells.Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer.
P2860
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Progression-free survival and ...... with first-line chemotherapy.
@en
Progression-free survival and ...... with first-line chemotherapy.
@nl
type
label
Progression-free survival and ...... with first-line chemotherapy.
@en
Progression-free survival and ...... with first-line chemotherapy.
@nl
prefLabel
Progression-free survival and ...... with first-line chemotherapy.
@en
Progression-free survival and ...... with first-line chemotherapy.
@nl
P2093
P2860
P1476
Progression-free survival and ...... with first-line chemotherapy.
@en
P2093
Atsushi Ohtsu
Kohei Shitara
P2860
P2888
P304
P356
10.1007/S00432-013-1452-Y
P577
2013-05-25T00:00:00Z